Pharmacokinetiks of Atomoxetine in plasma and oral fluid in pediatric patients with attention deficit/hyperactivity disorder
Introduction Atomoxetine (ATX) is the first non-psychostimulant drug indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients as an alternative to methylphenidate.
Gespeichert in:
| Veröffentlicht in: | Clinical therapeutics 2015-08, Vol.37 (8), p.e16-e16 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e16 |
|---|---|
| container_issue | 8 |
| container_start_page | e16 |
| container_title | Clinical therapeutics |
| container_volume | 37 |
| creator | Papaseit, E Garcia-Algar, O Aznar, G Marchei, E Pacifici, R Pichini, S Farré, M |
| description | Introduction Atomoxetine (ATX) is the first non-psychostimulant drug indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients as an alternative to methylphenidate. |
| doi_str_mv | 10.1016/j.clinthera.2015.05.056 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1693873129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S014929181500363X</els_id><sourcerecordid>3735386401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1899-c4b935a5abf0876f0ea29944ee900c156539f5fd383a76cd096a0376f3d0fa933</originalsourceid><addsrcrecordid>eNqNkd2KFDEQhRtRcFx9BgNe92zS6U53boRh8WdhQUGFvQu1SYWpmZ5Om2R2HfDhN-2IgldCQShy6qTynap6LfhacKEud2s70pS3GGHdcNGt-VLqSbUSQ69rIdrbp9WKi1bXjRbD8-pFSjvOudRds6p-ft5CPIANe5ow0z6x4Nkmh0P4UdoJGU1sHiEdgMHkWIgwMj8eyf26QEeQI1k2QyaccmIPlLcMci4NhYk59GQpX25Pc9nPZrqnfGKOUogO48vqmYcx4avf50X17f27r1cf65tPH66vNje1FYPWtW3vtOyggzvPh155jtBo3baImnMrOtVJ7Tvv5CChV9ZxrYDLIpSOe9BSXlRvzr5zDN-PmLLZhWOcypNGKC2HXopGF1V_VtkYUorozRzpAPFkBDcLarMzf1CbBbXhS6kyuTlPYvnEPWE0yRYctuCJaLNxgf7D4-0_HouOLIx7PGH6u7BJjeHmyxLokqfoSpRK3spHKVOjuw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1693873129</pqid></control><display><type>article</type><title>Pharmacokinetiks of Atomoxetine in plasma and oral fluid in pediatric patients with attention deficit/hyperactivity disorder</title><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Papaseit, E ; Garcia-Algar, O ; Aznar, G ; Marchei, E ; Pacifici, R ; Pichini, S ; Farré, M</creator><creatorcontrib>Papaseit, E ; Garcia-Algar, O ; Aznar, G ; Marchei, E ; Pacifici, R ; Pichini, S ; Farré, M</creatorcontrib><description>Introduction Atomoxetine (ATX) is the first non-psychostimulant drug indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients as an alternative to methylphenidate.</description><identifier>ISSN: 0149-2918</identifier><identifier>EISSN: 1879-114X</identifier><identifier>DOI: 10.1016/j.clinthera.2015.05.056</identifier><language>eng</language><publisher>Bridgewater: Elsevier Inc</publisher><subject>Attention deficit hyperactivity disorder ; Fluids ; Internal Medicine ; Medical Education ; Plasma</subject><ispartof>Clinical therapeutics, 2015-08, Vol.37 (8), p.e16-e16</ispartof><rights>2015</rights><rights>Copyright Elsevier Limited Aug 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1693873129?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976,64364,64368,72218</link.rule.ids></links><search><creatorcontrib>Papaseit, E</creatorcontrib><creatorcontrib>Garcia-Algar, O</creatorcontrib><creatorcontrib>Aznar, G</creatorcontrib><creatorcontrib>Marchei, E</creatorcontrib><creatorcontrib>Pacifici, R</creatorcontrib><creatorcontrib>Pichini, S</creatorcontrib><creatorcontrib>Farré, M</creatorcontrib><title>Pharmacokinetiks of Atomoxetine in plasma and oral fluid in pediatric patients with attention deficit/hyperactivity disorder</title><title>Clinical therapeutics</title><description>Introduction Atomoxetine (ATX) is the first non-psychostimulant drug indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients as an alternative to methylphenidate.</description><subject>Attention deficit hyperactivity disorder</subject><subject>Fluids</subject><subject>Internal Medicine</subject><subject>Medical Education</subject><subject>Plasma</subject><issn>0149-2918</issn><issn>1879-114X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkd2KFDEQhRtRcFx9BgNe92zS6U53boRh8WdhQUGFvQu1SYWpmZ5Om2R2HfDhN-2IgldCQShy6qTynap6LfhacKEud2s70pS3GGHdcNGt-VLqSbUSQ69rIdrbp9WKi1bXjRbD8-pFSjvOudRds6p-ft5CPIANe5ow0z6x4Nkmh0P4UdoJGU1sHiEdgMHkWIgwMj8eyf26QEeQI1k2QyaccmIPlLcMci4NhYk59GQpX25Pc9nPZrqnfGKOUogO48vqmYcx4avf50X17f27r1cf65tPH66vNje1FYPWtW3vtOyggzvPh155jtBo3baImnMrOtVJ7Tvv5CChV9ZxrYDLIpSOe9BSXlRvzr5zDN-PmLLZhWOcypNGKC2HXopGF1V_VtkYUorozRzpAPFkBDcLarMzf1CbBbXhS6kyuTlPYvnEPWE0yRYctuCJaLNxgf7D4-0_HouOLIx7PGH6u7BJjeHmyxLokqfoSpRK3spHKVOjuw</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Papaseit, E</creator><creator>Garcia-Algar, O</creator><creator>Aznar, G</creator><creator>Marchei, E</creator><creator>Pacifici, R</creator><creator>Pichini, S</creator><creator>Farré, M</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20150801</creationdate><title>Pharmacokinetiks of Atomoxetine in plasma and oral fluid in pediatric patients with attention deficit/hyperactivity disorder</title><author>Papaseit, E ; Garcia-Algar, O ; Aznar, G ; Marchei, E ; Pacifici, R ; Pichini, S ; Farré, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1899-c4b935a5abf0876f0ea29944ee900c156539f5fd383a76cd096a0376f3d0fa933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Attention deficit hyperactivity disorder</topic><topic>Fluids</topic><topic>Internal Medicine</topic><topic>Medical Education</topic><topic>Plasma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Papaseit, E</creatorcontrib><creatorcontrib>Garcia-Algar, O</creatorcontrib><creatorcontrib>Aznar, G</creatorcontrib><creatorcontrib>Marchei, E</creatorcontrib><creatorcontrib>Pacifici, R</creatorcontrib><creatorcontrib>Pichini, S</creatorcontrib><creatorcontrib>Farré, M</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Clinical therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Papaseit, E</au><au>Garcia-Algar, O</au><au>Aznar, G</au><au>Marchei, E</au><au>Pacifici, R</au><au>Pichini, S</au><au>Farré, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetiks of Atomoxetine in plasma and oral fluid in pediatric patients with attention deficit/hyperactivity disorder</atitle><jtitle>Clinical therapeutics</jtitle><date>2015-08-01</date><risdate>2015</risdate><volume>37</volume><issue>8</issue><spage>e16</spage><epage>e16</epage><pages>e16-e16</pages><issn>0149-2918</issn><eissn>1879-114X</eissn><abstract>Introduction Atomoxetine (ATX) is the first non-psychostimulant drug indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients as an alternative to methylphenidate.</abstract><cop>Bridgewater</cop><pub>Elsevier Inc</pub><doi>10.1016/j.clinthera.2015.05.056</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0149-2918 |
| ispartof | Clinical therapeutics, 2015-08, Vol.37 (8), p.e16-e16 |
| issn | 0149-2918 1879-114X |
| language | eng |
| recordid | cdi_proquest_journals_1693873129 |
| source | Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
| subjects | Attention deficit hyperactivity disorder Fluids Internal Medicine Medical Education Plasma |
| title | Pharmacokinetiks of Atomoxetine in plasma and oral fluid in pediatric patients with attention deficit/hyperactivity disorder |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T23%3A32%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetiks%20of%20Atomoxetine%20in%20plasma%20and%20oral%20fluid%20in%20pediatric%20patients%20with%20attention%20deficit/hyperactivity%20disorder&rft.jtitle=Clinical%20therapeutics&rft.au=Papaseit,%20E&rft.date=2015-08-01&rft.volume=37&rft.issue=8&rft.spage=e16&rft.epage=e16&rft.pages=e16-e16&rft.issn=0149-2918&rft.eissn=1879-114X&rft_id=info:doi/10.1016/j.clinthera.2015.05.056&rft_dat=%3Cproquest_cross%3E3735386401%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1693873129&rft_id=info:pmid/&rft_els_id=S014929181500363X&rfr_iscdi=true |